83 related articles for article (PubMed ID: 10029091)
21. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
22. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
[TBL] [Abstract][Full Text] [Related]
24. Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells.
Corral RS; Iñiguez MA; Duque J; López-Pérez R; Fresno M
Oncogene; 2007 Feb; 26(7):958-69. PubMed ID: 16909108
[TBL] [Abstract][Full Text] [Related]
25. Expression of gastrin-releasing peptide receptors in endometrial cancer.
Levine L; Licci JA; Townsend CM; Hellmich MR
J Am Coll Surg; 2003 Jun; 196(6):898-904. PubMed ID: 12788426
[TBL] [Abstract][Full Text] [Related]
26. Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.
Taglia L; Matusiak D; Matkowskyj KA; Benya RV
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G182-90. PubMed ID: 16920698
[TBL] [Abstract][Full Text] [Related]
27. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
28. Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells.
Frankel A; Tsao MS; Viallet J
Cancer Res; 1994 Apr; 54(7):1613-6. PubMed ID: 8137267
[TBL] [Abstract][Full Text] [Related]
29. Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
Ali M; Gawin AZ; Baraniuk JN
J Pharmacol Exp Ther; 1996 Mar; 276(3):1266-71. PubMed ID: 8786559
[TBL] [Abstract][Full Text] [Related]
30. Bombesin: a possible role in wound repair.
Baroni A; Perfetto B; Canozo N; Braca A; Farina E; Melito A; De Maria S; Cartenì M
Peptides; 2008 Jul; 29(7):1157-66. PubMed ID: 18455266
[TBL] [Abstract][Full Text] [Related]
31. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells.
Aprikian AG; Han K; Chevalier S; Bazinet M; Viallet J
J Mol Endocrinol; 1996 Jun; 16(3):297-306. PubMed ID: 8782088
[TBL] [Abstract][Full Text] [Related]
32. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.
Burns DM; Walker B; Gray J; Nelson J
Br J Cancer; 1999 Jan; 79(2):214-20. PubMed ID: 9888460
[TBL] [Abstract][Full Text] [Related]
35. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV
Cell Growth Differ; 2000 Jul; 11(7):385-93. PubMed ID: 10939592
[TBL] [Abstract][Full Text] [Related]
36. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder R; Reubi JC
Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
[TBL] [Abstract][Full Text] [Related]
37. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
Fleischmann A; Waser B; Reubi JC
Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
[TBL] [Abstract][Full Text] [Related]
38. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
Kiaris H; Schally AV; Nagy A; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 1999 Nov; 81(6):966-71. PubMed ID: 10576652
[TBL] [Abstract][Full Text] [Related]
39. Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.
Keller G; Schally AV; Nagy A; Halmos G; Baker B; Engel JB
Cancer; 2005 Nov; 104(10):2266-74. PubMed ID: 16211544
[TBL] [Abstract][Full Text] [Related]
40. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
